Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Long-term safety profile of mitoxantrone in a French cohort of 802 multiple sclerosis patients: a 5-year prospective study.
Headwaters of the zebrafish -- emergence of a new model vertebrate.
Immunopathology: autoimmune glial diseases and differentiation from multiple sclerosis.
Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy.
Interferon beta-1b therapy in chronic viral dilated cardiomyopathy--is there a role for specific therapy?
Efficacy of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: integrated analysis of the phase 3 trials.
Development of a recombinant immunotoxin for the immunotherapy of autoreactive lymphocytes expressing MOG-specific BCRs.
Flupirtine as neuroprotective add-on therapy in autoimmune optic neuritis.
Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome.
A Multiple-Dose, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group QT/QTc Study to Evaluate the Electrophysiologic Effects of THC/CBD Spray.
Interferon-beta1b for the treatment of multiple sclerosis.
Tolerability and pharmacokinetics of delayed-release dimethyl fumarate administered with and without aspirin in healthy volunteers.
Switching patients at high risk of PML from natalizumab to another disease-modifying therapy.
Leflunomide: mode of action in the treatment of rheumatoid arthritis.
Onset of psoriasis upon interferon beta treatment in a multiple sclerosis patient.
Clobetasol promotes remyelination in a mouse model of neuromyelitis optica.
EU regulator warns on possible MS drugs side effects
The budget impact of introducing delayed-release dimethyl fumarate for treatment of relapse-remitting multiple sclerosis in Canada.
A map of the human neocortex showing the estimated overall myelin content of the individual architectonic areas based on the studies of Adolf Hopf.
FGF-1 Triggers Pannexin-1 Hemichannel Opening in Spinal Astrocytes of Rodents and Promotes Inflammatory Responses in Acute Spinal Cord Slices.
Dimethyl fumarate-associated lymphopenia: Risk factors and clinical significance.
Cognitive dysfunction in patients with multiple sclerosis treated with different types of interferon beta: A randomized clinical trial.
Artesunate Ameliorates Experimental Autoimmune Encephalomyelitis by Inhibiting Leukocyte Migration to the Central Nervous System.
Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 clinical trial.
Efficacy and safety of delayed-release dimethyl fumarate in patients newly diagnosed with relapsing-remitting multiple sclerosis (RRMS).

Pages